Patent classifications
A61F2/2875
ULTRA-SOUND COMPATIBLE ARTIFICIAL CRANIAL PROSTHESIS WITH CUSTOMIZED PLATFORMS
An intracranial prosthesis comprised of a relatively flat, ultrasound-compatible body capable of engaging a plurality of diagnostic instruments and/or intracranial delivery systems so that a practicing medical professional can monitor certain parameters of a patient or deliver therapeutic agents to the patient while using an ultrasound-monitoring device to image the patient's brain. The prosthesis is designed to allow for the continuous, uninterrupted, simultaneous monitoring of a number of parameters of a patient's brain at the patient's bedside.
COMPOUND PLATE FOR CRANIOTOMY CLOSURES
Disclosed is a compound bone plate for attaching a bone flap to a skull. The compound bone plate can include a first plate member, a second plate member, a burr hole cover, and a strut. The first plate member can be operable to be attached to the bone flap and the skull. The second plate member can be operable to be attached to the bone flap and the skull. The strut can connect the first plate member, the second plate member, and the burr hole cover.
Method for performing single-stage cranioplasty reconstruction with a clear custom cranial implant
A method for single-stage cranioplasty reconstruction includes prefabricating a clear craniofacial implant, creating a cranial, craniofacial, and/or facial defect, positioning the clear craniofacial implant over the cranial, craniofacial, and/or facial defect, tracing cut lines on the clear craniofacial implant as it lies over the cranial, craniofacial, and/or facial defect, cutting the prefabricated clear custom craniofacial implant along the hand-marked lines for optimal fit of the clear implant within the cranial, craniofacial, and/or facial defect, and attaching the final clear craniofacial implant to the cranial, craniofacial, and/or facial defect with standard fixation methods of today.
Resorbable crosslinked form stable membrane for use outside the oral cavity
The invention relates to resorbable crosslinked form stable membrane which comprises a composite layer of collagen material and inorganic ceramic particles containing 1.5 to 3.5 weight parts of inorganic ceramic for 1 weight part of collagen material, sandwiched between two layers of elastic pretensed collagen material (collagen material that has been stretched such as to be in the linear/elastic region of the stress-strain curve), the collagen material comprising 50-100% (w/w) collagen and 0-50% (w/w) elastin, and has shape and dimensions suitable for use in human tissue regeneration outside the oral cavity in rhinoplasty, postlateral spinal fusion or orbital reconstruction.
Bone implants and methods for correcting bone defects
A bone implant including a wire mesh support frame having a plurality of interconnected wire members and at least two fastening points in the form of retention eyelets connected to the support frame by at least one of the wire members, and a biocompatible plate formed about the support frame, the plate having a bore associated with each of the retention eyelets.
Translucent in-vivo indwelling device and utilization thereof
A translucent in-vivo indwelling device with a translucent region including a rare earth doped fluorapatite.
SYSTEM AND METHOD FOR FORMING MATERIAL LAYERS FOR SURGICAL APPLICATIONS
The present disclosure sets forth a system and method for forming sheets of material, such as titanium mesh or plates, for surgical applications prior to surgery. The disclosed solutions provide this capability without incurring expense from use of PEEK or PEKK by manufacturing contoured plates based on a shape of an anatomical structure in a 3D image, such as a pre-defect MRI. The contoured plates are used to stamp the titanium mesh, plate, or other sheet of material into the shape of the bone prior to the defect. In some aspects, the mesh or other material layer can also be trimmed prior to surgery using, for example, a reproduction of the anatomical structure manufactured from a post-defect MRI of the same anatomical structure.
Soft tissue implant and method of using same
A soft tissue implant for correction of temporalis depressions or hollowing. The implant has a symmetric shape or external configuration, so that the device may be used as either a right or left temporalis implant. The implant may lie under or on top of the remaining temporalis muscle, or in the location formerly occupied by the temporalis muscle, to correct post-craniectomy temporal hollowing. The implant is manufactured from a medical grade, long term implantable silicone polymer material. The implant has a shell which forms the base of the device, with the base having an exterior surface and an interior surface with spaced projecting support structures. The implant is fully flexible or bendable.
MODULAR TISSUE SCAFFOLDS
Provided are biocompatible and implantable scaffolds for treating a tissue defect, such as a bone gap. The scaffolds can have a modular design comprising a tissue scaffold rack designed to accommodate one or more modules. Also provided are methods for fabrication and use of such scaffolds.
PATIENT-SPECIFIC CRANIOFACIAL IMPLANTS
Patient-specific craniofacial implants structured for filling bone voids or planned bone voids in the cranium and face as well as for simultaneously providing soft tissue reconstruction and/or augmentation for improved aesthetic symmetry and appearance of face and skull. Pterional or temporal voids or defects generally result from a chronic skull or lateral facial deformity along with a compromised temporalis muscle or soft tissue distortion from previous surgery. When muscle and fat atrophy occurs in the pterion or temporal face, temporal hollowing deformity generally results where there would be soft tissue but for the atrophy. The patient-specific craniofacial implants with dual-purpose herein are configured to have an augmented region adjacent the temporal region of the face and cranium in order to prevent and/or correct any such temporal hollowing deformity and to utilize this newfound space to strategically embed implantable neurotechnologies for improved outcomes.